兆科眼科与PT. Erela签印尼独家分销协议
2026-06-05 09:07:35
兆科眼科（6622）宣布，与印尼制药公司PT. Erlangga Edi Laboratories（PT. Erela）就用于治疗中重度干眼症的创新药环孢素眼用凝胶在印尼商业化，订立分销及供应协议。据明报报道，兆科眼科授予PT. Erela在印尼注册、进口、推广、分销、营销及销售该产品的独家权利，并将收取一笔预付款项，且可按特定成就获得额外里程碑付款。
Disclaimer:
1. The information provided does not constitute investment advice. Investors should make independent decisions and bear all risks themselves.
2. The copyright of this content belongs to the original author. The views expressed herein are solely those of the author and do not represent the stance or position of this website.
Previous article：
港股沽空额697.69亿 占比降至20.35%
